By the Top Tier Newswire AI Desk · November 4, 2026 at 10:38 AM ET · reviewed against 3 wire stories
LIQUIDIA CORP (LQDA) is up +13.22% in the latest session. Our newswire has captured 3 stories on LQDA across 3 sources in the last 36 hours, with AI sentiment reading mixed (avg 50/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Liquidia Corporation (Nasdaq: LQDA) shares rose 13.22% to $47.78 on Monday. The primary driver for the move is the company’s announcement that it will report third quarter 2026 financial results on November 10, 2026. This scheduled earnings release follows a period of strong fundamental growth and recent analyst upgrades.
What Happened
Liquidia disclosed on November 3 that it will release its third quarter 2026 financial results on November 10. The company, a biopharmaceutical firm focused on respiratory and vascular care, is preparing for this upcoming disclosure after a period of significant revenue expansion. In the same timeframe, HC Wainwright & Co. maintained its Buy rating on the stock and raised its price target to $65. Additionally, RBC noted that United Therapeutics’ Tyvaso outlook faces near-term pressure following a settlement involving Liquidia. These developments occurred against a backdrop of three news stories published in the last 36 hours.
What The Data Shows
The stock opened at $42.51, a 0.7% gap up from the prior close of $42.20. The session low was $42.21 at 8:10 AM ET, while the session high reached $51.11 at 9:40 AM ET. Volume so far stands at 1.8 million shares, which is 0.6 times the 3-month daily average. Fundamentals show a market cap of $3.7 billion, a P/E of 28.6, and TTM revenue growth of 2233.6%. The net margin is 30.7%, and the beta is 0.41. The 52-week range is $22.21 to $93.61. Over the last 8 sessions, the stock moved down 1.1% from $42.65 to $42.20. On November 4, the stock printed 9 fresh 52-week highs and 1 fresh 52-week low. Insider activity includes 17 sells totaling $25.8 million in the last 90 days, with no buys. Recent Form 4 filings show sales by Chief Accounting Officer Dana Boyle and Chief Business Officer Jason Adair on October 26 and October 12. Congressional disclosures show three sales by Donald J. Trump in July and August 2026.
What To Watch
The key date to monitor is November 10, 2026, when Liquidia will report its third quarter 2026 financial results.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
LQDA · today's session (5-min) · +11.37% vs prior close · updated 4:11 PM ETAI sentiment, last 36h · averaged over 3 stories · 50/100 neutral
The headlines behind the move
Story flow · 3 stories on the wire, last 36h · hover or tap a dot for the headline
1d agoInvesting.com MarketsNEUTRAL 50Earnings
Liquidia stock may move 6.5% on Nov. 10 earnings release
Liquidia stock may move 6.5% on Nov. 10 earnings release
1d agoGlobeNewswireNEUTRAL 50General
Liquidia Corporation to Report Third Quarter 2026 Financial Results on November 10, 2026
MORRISVILLE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced...
1d agoBusiness InsiderNEUTRAL 50General
Liquidia Corporation to Report Third Quarter 2026 Financial Results on November 10, 2026
MORRISVILLE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →